<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03532724</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-ORI-2017-45</org_study_id>
    <nct_id>NCT03532724</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes From Patient Self-management of Antivitamin K Treatment</brief_title>
  <acronym>ORION</acronym>
  <official_title>Retrospective Analysis of the Clinical Outcomes From Patient Self-management of Antivitamin K Treatment at the Hospitald de Sant Pau. ORION Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      ORION is a retrospective, observational, one center study to evaluate the incidence of
      complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K
      antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa
      Creu i Sant Pau in Barcelona (Spain)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thromboembolic events</measure>
    <time_frame>since 1 of july of 2002 to 30th of june of 2018</time_frame>
    <description>Any documented embolic stroke, peripheral arterial embolism or venous thromboembolism</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major hemorrhagic event</measure>
    <time_frame>since 1 of july of 2002 to 30th of june of 2018</time_frame>
    <description>Any documented bleeding event grade 3 or 5 in the Bleeding Assessment Research Consortium (BARC) scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>since 1 of july of 2002 to 30th of june of 2018</time_frame>
    <description>Death from any cause</description>
  </secondary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Self Management of Oral Anticoagulation With VKA Therapy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient Self-Management of VKA therapy</intervention_name>
    <description>Trained patients check weekly the INR using a portable coagulometer an decide by themselves the dosis of VKA</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from atrial fibrillation, or carrying a cardiac mechanical valve
        prostheses, or suffering any other cardiac disease with risk of arterial embolism or with a
        previous venous thromboembolic event with high risk of recurrence, and receiving chronic
        oral anticoagulation (OA) with any VKA drug, and whom have been trained in our Unit by
        specialized nurses on self-management of their OA by using a portable coagulometer to
        weekly test the International Normalized Ratio (INR)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult patients (older than 18) under chronic VKA treatment, whom performed patient
             self-management for any indication of oral anticoagulation.

          2. Signed informed consent

        Exclusion Criteria:

        1. Patients younger than 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan C Souto, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de la santa Creu i Sant Pau. Barcelona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan C Souto, MD, PhD</last_name>
    <phone>34-654633993</phone>
    <email>jsouto@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hspital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan C Souto, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2018</study_first_submitted>
  <study_first_submitted_qc>May 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patient Self-management, Acenocoumarol, Warfarin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antivitamins K</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

